This inventor holds 1 USPTO granted patent. Top assignee: Astellas Pharma Gmbh. Active years: 2014.
Company Filing History:
Years Active: 2014
Title: Keni Ni - Innovator in Pharmaceutical Chemistry
Introduction
Keni Ni is a notable inventor based in Chuo-ku, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that can aid in the treatment of various mental health conditions.
Latest Patents
Keni Ni holds a patent for an imidazo[1,2-a]pyridine derivative. This compound is designed to provide a solution for treating or preventing schizophrenia, Alzheimer's disease, dementia, and depression. The invention addresses the need for a compound with PDE4B inhibitory activity, which is crucial for the effectiveness of the treatment. The research led to the discovery that a tricyclic or tetracyclic imidazo[1,2-a]pyridine derivative or its salts exhibit superior PDE4B inhibitory activity.
Career Highlights
Keni Ni is currently associated with Astellas Pharma GmbH, where he continues to work on innovative solutions in the pharmaceutical industry. His research has the potential to impact the lives of many individuals suffering from mental health disorders.
Collaborations
Keni Ni collaborates with esteemed colleagues such as Kiyohiro Samizu and Naoyuki Masuda. Their combined expertise contributes to the advancement of research in the field.
Conclusion
Keni Ni's work exemplifies the importance of innovation in medicine, particularly in developing treatments for complex mental health issues. His contributions through patents and collaboration with other professionals highlight the ongoing efforts to improve healthcare solutions.